Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin.
about
Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability.Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.Carvedilol nano lipid carriers: formulation, characterization and in-vivo evaluation.Preparation and evaluation of self-nanoemulsifying tablets of carvedilol.Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.Drug solubility: importance and enhancement techniques.Aripiprazole-cyclodextrin binary systems for dissolution enhancement: effect of preparation technique, cyclodextrin type and molar ratio.Solid State Characterization of Domperidone: Hydroxypropyl-β-Cyclodextrin Inclusion Complex.Carvedilol: solubilization and cyclodextrin complexation: a technical note.Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration.1H and 13C NMR characteristics of β-blockers.Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside.Cyclodextrin facilitated electrospun chitosan nanofibersStructure and pharmacological studies of the anaesthetic 1-(3-n-butoxypropyl)-4-benzoyloxypiperidin hydrochloride and its complex with β-cyclodextrin in solution. NMR and IR-spectroscopy dataImprovement of Water Solubility of Josamycin by Inclusion Complex with -CyclodextrinPhysicochemical Characterization and Cyclodextrin Complexation of the Anticancer Drug Lapatinib
P2860
Q30459146-F463C057-B4BD-4FE4-8280-E2294BBC1729Q35577222-28BDD214-7978-4AC3-965A-00B658C54557Q35957617-7AF6507D-BB63-479D-8A3A-D9660285B058Q37146180-8596B95C-4F74-4182-8234-A73D95681AD1Q39769144-892F68BE-0451-4347-A909-AF3BEE21BFDBQ41500018-26607695-6F57-4744-BDCE-EEE7CD423FCCQ41885580-2FBE5C93-DC51-481B-B90D-93DC8A8F8AF9Q41975966-3EDAA9F4-9BBC-418B-AF5D-E710ABF37C5DQ42087553-296DD7DD-8D2A-439C-859E-1B5D9F1A7C56Q42374191-4AA0A126-FC58-418E-BF54-4FF8A6995755Q43216548-6330A108-4820-4229-9097-7CBA0FD4C783Q46871574-67DED797-E038-416B-8DF8-1D20C532016FQ54958449-7BA16A5A-82D9-4B8C-A742-D2DE37B27633Q57439929-3F62AF78-DE47-4E34-9D9F-978E6B41C9D4Q57952990-7EAA3434-D3D8-4782-A6C5-3ACF428C45EDQ58692042-01AA9EAD-4358-43C0-AC4F-5F194C0F7056Q59145850-8F0EEE50-B920-4148-B193-E29E1C15F8B8
P2860
Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin.
@en
Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin.
@nl
type
label
Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin.
@en
Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin.
@nl
prefLabel
Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin.
@en
Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin.
@nl
P2093
P1476
Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin.
@en
P2093
Xianhong Wen
Zhijun Jing
Ziuyang Liu
P304
P356
10.1016/S0731-7085(03)00576-4
P577
2004-02-01T00:00:00Z